Viatris

VTRS-Q

NASDAQ:VTRS

13.40
0.12 (0.90%)
Mylan N.V. is an American global generic and specialty pharmaceuticals company registered in the Netherlands, with principal executive offices in Hatfield, Hertfordshire, UK and global headquarters in Canonsburg, Pennsylvania, US.
More at Wikipedia

Analysis and Opinions about VTRS-Q

Signal
Opinion
Expert
COMMENT
COMMENT
February 11, 2021

VTRS vs. TMO VTRS has lower growth assets with fairly consistent cashflows. TMO is into tools and diagnostics. 75% of TMO's business is consumables. It's benefitting significantly from Covid, and this should continue. They blew away estimates, and so you pay a bit more for it.

Show full opinionHide full opinion
Viatris (VTRS-Q)
February 11, 2021

VTRS vs. TMO VTRS has lower growth assets with fairly consistent cashflows. TMO is into tools and diagnostics. 75% of TMO's business is consumables. It's benefitting significantly from Covid, and this should continue. They blew away estimates, and so you pay a bit more for it.

Paul MacDonald
Price
$18.205
Owned
Unknown
TOP PICK
TOP PICK
December 22, 2020

Brand new company from the merger if Mylan and Upjohn. Trades at 6x earnings and nobody has covered this. This stock will trade at 10-11x earnings, nearly doubling. This is his most compelling top pick today. The company is already generating profits and cash flow. They make Xoloft, Viagra, Lipotor mostly from Upjohn. They also have a pipeline of new drugs company. Seasoned managers. (Analysts’ price target is $22.43)

Show full opinionHide full opinion
Viatris (VTRS-Q)
December 22, 2020

Brand new company from the merger if Mylan and Upjohn. Trades at 6x earnings and nobody has covered this. This stock will trade at 10-11x earnings, nearly doubling. This is his most compelling top pick today. The company is already generating profits and cash flow. They make Xoloft, Viagra, Lipotor mostly from Upjohn. They also have a pipeline of new drugs company. Seasoned managers. (Analysts’ price target is $22.43)

Lorne Steinberg
Price
$17.740
Owned
Yes
Showing 1 to 2 of 2 entries
  • «
  • 1
  • »

Viatris(VTRS-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Viatris is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Viatris(VTRS-Q) Frequently Asked Questions

What is Viatris stock symbol?

Viatris is a American stock, trading under the symbol VTRS-Q on the NASDAQ (VTRS). It is usually referred to as NASDAQ:VTRS or VTRS-Q

Is Viatris a buy or a sell?

In the last year, there was no coverage of Viatris published on Stockchase.

Is Viatris a good investment or a top pick?

Viatris was recommended as a Top Pick by Paul MacDonald on 2021-02-11. Read the latest stock experts ratings for Viatris.

Why is Viatris stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Viatris worth watching?

0 stock analysts on Stockchase covered Viatris In the last year. It is a trending stock that is worth watching.

What is Viatris stock price?

On 2021-04-16, Viatris (VTRS-Q) stock closed at a price of $13.4.